HK1010447A1 - Tramadol salt containing medicaments with sustained release of the active ingredient - Google Patents

Tramadol salt containing medicaments with sustained release of the active ingredient Download PDF

Info

Publication number
HK1010447A1
HK1010447A1 HK98111000A HK98111000A HK1010447A1 HK 1010447 A1 HK1010447 A1 HK 1010447A1 HK 98111000 A HK98111000 A HK 98111000A HK 98111000 A HK98111000 A HK 98111000A HK 1010447 A1 HK1010447 A1 HK 1010447A1
Authority
HK
Hong Kong
Prior art keywords
release
weight
celluloses
pharmaceutically acceptable
active ingredient
Prior art date
Application number
HK98111000A
Other languages
German (de)
English (en)
French (fr)
Chinese (zh)
Other versions
HK1010447B (en
Inventor
Antonius Bartholomaus Johannes Heinrich
Original Assignee
Grunenthal Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6496771&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1010447(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Grunenthal Gmbh filed Critical Grunenthal Gmbh
Publication of HK1010447A1 publication Critical patent/HK1010447A1/xx
Publication of HK1010447B publication Critical patent/HK1010447B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/2853—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers, poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK98111000.8A 1993-09-03 1998-09-28 Tramadol salt containing medicaments with sustained release of the active ingredient HK1010447B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4329794A DE4329794C2 (de) 1993-09-03 1993-09-03 Tramadolsalz enthaltende Arzneimittel mit verzögerter Wirkstofffreisetzung
DE4329794 1993-09-03

Publications (2)

Publication Number Publication Date
HK1010447A1 true HK1010447A1 (en) 1999-06-17
HK1010447B HK1010447B (en) 1999-06-17

Family

ID=

Also Published As

Publication number Publication date
PL304860A1 (en) 1995-03-06
JPH07196482A (ja) 1995-08-01
ES2119034T3 (es) 1998-10-01
HUT70438A (en) 1995-10-30
ECSP941148A (es) 1995-01-16
MY111754A (en) 2000-12-30
UY23804A1 (es) 1994-07-22
PE10195A1 (es) 1995-03-31
ATE166575T1 (de) 1998-06-15
JP3954117B2 (ja) 2007-08-08
LT3664B (en) 1996-01-25
HU9402478D0 (en) 1994-10-28
EP0642788A2 (de) 1995-03-15
CZ214094A3 (en) 1995-03-15
AU7280394A (en) 1995-03-16
KR100325494B1 (ko) 2002-06-22
RU94032150A (ru) 1996-11-10
LTIP2033A (en) 1995-03-27
DE4329794A1 (de) 1995-03-09
FI944035A0 (fi) 1994-09-02
IL109800A (en) 2000-06-01
CO4290295A1 (es) 1996-04-17
RU2138253C1 (ru) 1999-09-27
PL177315B1 (pl) 1999-10-29
EP0642788A3 (OSRAM) 1995-04-12
FI113336B (fi) 2004-04-15
CN1106656A (zh) 1995-08-16
ZA946775B (en) 1995-04-21
IL109800A0 (en) 1994-08-26
CA2131350A1 (en) 1995-03-04
FI944035L (fi) 1995-03-04
CA2131350C (en) 2005-08-16
CN1092956C (zh) 2002-10-23
CZ288832B6 (cs) 2001-09-12
SI0642788T1 (en) 1998-08-31
AU671384B2 (en) 1996-08-22
DE59406075D1 (de) 1998-07-02
DE4329794C2 (de) 1997-09-18
DK0642788T3 (da) 1999-01-18
KR950007841A (ko) 1995-04-15
UA26455C2 (uk) 1999-08-30
US5601842A (en) 1997-02-11
HU215955B (hu) 1999-03-29
EP0642788B1 (de) 1998-05-27
BR9403030A (pt) 1995-05-02

Similar Documents

Publication Publication Date Title
RU2138253C1 (ru) Лекарственное средство с замедленным высвобождением активнодействующего вещества
FI83037B (fi) Foerfarande foer framstaellning av en naproxen och natrium naproxentablett med styrd utloesning.
EP0797991B1 (en) Extended release formulation containing venlafaxine
US5599577A (en) Simethicone containing pharmaceutical compositions
US20110177168A1 (en) Composition
AU2002322964B2 (en) Dosage forms having prolonged active ingredient release
EP3878445A2 (en) Acamprosate formulations, methods of using the same, and combinations comprising the same
EP1177788B1 (en) Pharmaceutical composition of fluoxetin in coated dispersible tablets and process for its manufacture
NZ200244A (en) Gallopamil or verapamil as calcium-antagonistic active compounds in sustained release pharmaceutical compositions
WO2004078111A2 (en) Extended release minocycline compositions and processes for their preparation
WO2004096186A1 (en) Extended release venlafaxine tablet formulation
AU2003215671A1 (en) Sustained release formulation of tramadol
WO2003082261A1 (en) Extended release venlafaxine formulations
AU2006291422B2 (en) 3-(2-dimethylaminomethyl cyclohexyl) phenol retard formulation
HK1010447B (en) Tramadol salt containing medicaments with sustained release of the active ingredient
EP1331003B1 (en) Extended release formulation containing venlafaxine
CA2343270C (en) Methazolamide compositions and method of use
WO2008038106A1 (en) Venlafaxine extended release formulations
AU2003285739B2 (en) Extended release venlafaxine tablet formulation
JP2006509789A (ja) 不安症治療法及び治療薬
KR20030023240A (ko) 비타민 ｄ 경구투여용 서방성 약제 조성물
HK1056686B (en) Extended release formulation containing venlafaxine
HK1068539B (en) Pharmaceutical containing 3-(3-dimethylamino-1-ethyl-2-methyl-propyl)phenol and providing delayed release of the active ingredient
HK1068539A1 (en) Pharmaceutical containing 3-(3-dimethylamino-1-ethyl-2-methyl-propyl)phenol and providing delayed release of the active ingredient
AU6544200A (en) Extended release formulation

Legal Events

Date Code Title Description
PF Patent in force
PE Patent expired

Effective date: 20140823